Deep Tech Startups
6,157 companies tagged Deep Tech, with their investors and founders.
Capoom provides 3D modeling, 3D scanning, and synthetic data solutions for AI training, simulations, and digital twins across various industries.
1 investor
Capsida Biotherapeutics develops engineered gene therapies for rare and common neurological and ocular diseases using an AAV capsid platform that enables improved brain and retinal delivery compared to naturally occurring capsids. The company targets both central nervous system and ophthalmology conditions across all ages.
1 investor
Capuchin is an AI-powered enterprise search and knowledge management platform designed for engineering organizations that work with hardware, antennas, RF systems, optics, robotics, and similar technical products. The system operates entirely on-premise, indexing product data from PDM/PLM systems, ERPs, and collaboration tools while maintaining ITAR and CMMC compliance for defense and government-facing engineering teams.
1 investor
CapyBio provides tools to measure how closely cells match a target identity and to improve them, helping scientists and biopharma teams reduce failure in drug discovery, build stronger disease models, and advance cell-based therapies. The company applies cell biology and computational methods to cell identity for research, testing, and regenerative medicine.
1 investor
Carbo Energy builds hybrid non-aqueous redox flow batteries for grid-scale energy storage, designed to complement renewable energy sources with a 40-year lifespan, zero fire risk, and degradation of 0.2% annually. The company serves utilities, datacenters, mining operations, and renewable energy farms across multiple markets including energy trading, backup power, and off-grid operations.
1 investor
Carbon Cell is a team of designers, engineers, and scientists developing sustainable materials aimed at reducing plastic use and carbon emissions. The company operates in the sustainable materials and climate space.
1 investor
Carbon Clean Energy develops carbon conversion technology that transforms CO2 into chemicals, materials, and fuels using an artificial photosynthesis approach powered by renewable energy. The company serves industrial manufacturers and enterprises seeking decarbonization solutions and carbon-neutral product alternatives.
1 investor
Carbonext produces high-quality 3D graphene using a scalable chemical process that substitutes graphite with biomass and industrial waste materials. The company targets commercial applications by reducing graphene production costs and enabling bulk supply at scale.
1 investor
Carocell Bio develops peptide-based anti-inflammatory therapeutics, including its lead peptide JEL0305, that inhibit the intracellular MAPK (p38) inflammatory pathway and are combined with a nanoparticle delivery technology for topical application to the skin. It targets inflammatory conditions such as eczema (atopic dermatitis) and inflammation-related skin ageing.
1 investor
Carroucell develops microcarrier technology for cell and gene therapy applications, enabling cost-effective bioproduction and cell amplification. The company serves the healthcare and biomanufacturing industries with sol-gel based microcarrier solutions.
1 investor
Carterra develops surface plasmon resonance (SPR) platforms for high-throughput biomolecular interaction analysis. The systems are designed for drug discovery, antibody development, and screening applications in research and biotech organizations.
1 investor
Carus Bio develops next-generation in vivo CAR-T therapeutics using an mRNA delivery platform technology for cell and gene therapy. The company focuses on treatments for patients in the biotech and cell-gene therapy field.
1 investor
Cascade Geomatics provides hardware and software for geotechnical monitoring, offering early warning systems for mining pit walls, benches, and haul roads, as well as always-on corridor monitoring for slopes and rail track. Its products serve mining and infrastructure operators managing ground-stability risks.
1 investor
Cassidy Bio develops a genomic foundation model that accelerates CRISPR gene editing therapy design by predicting optimal guides, editors, and delivery approaches. The platform enables therapeutic teams to move from multi-year trial-and-error to weeks of computational validation, shortening development timelines for life-saving genome editing medicines.
1 investor
CAST develops film piezoelectric sensors that are heat-resistant, flexible, and thin, used as measurement systems for industrial monitoring. Its products include a pipe wall thinning monitoring system for detecting structural degradation.
1 investor
Catalera develops biopesticide solutions using patented formulation technology for biological active ingredients. The company offers fungicides, insecticides, and miticides registered for use across consumer, professional, and agricultural applications in the United States.
1 investor
CatAmmon develops nano-ceramic catalysts intended to replace scarce platinum-group metals (PGMs) in applications such as automotive catalytic converters and ammonia cracking for hydrogen production. The company targets emission control systems and alternative energy markets with lower-cost, scalable advanced materials.
1 investor
Category Labs builds high-performance decentralized systems, including Monad, a fully EVM-compatible layer 1 blockchain designed for high throughput, fast block times, single-slot finality, and low hardware requirements. Its team draws on backgrounds in high-frequency trading and low-level systems engineering.
1 investor
CatSci is a contract research and development partner for medicines development, uniting chemistry, bioscience, analytical science, and solid-state development into integrated process development and route optimisation services. It serves large pharma, biotech, and academia clients across drug modalities, operating from sites in the UK and Europe.
1 investor
Causeway Sensors makes a compact device that measures IgG concentration directly from bioreactor samples, providing at-line, real-time data for bioproduction processes. It serves bioprocessing and biomanufacturing teams.
1 investor
Cbio develops next-generation T-cell therapies for solid tumors, which account for the majority of cancers. Its lead product, novoleucel, is a minimally invasive cell therapy designed to improve clinical outcomes and survival for late-stage cancer patients.
1 investor
Cebina is an early-stage biotech investor and incubator that funds and de-risks pre-company and startup drug development projects across pre-seed, seed, and Series A stages. It focuses on therapeutic areas including cardiovascular and metabolic diseases, lung fibrosis, cancer immunotherapy, and anti-infectives, and also pursues co-development and licensing partnerships.</parameter> <parameter name="founders">[]
1 investor
Cedana provides infrastructure software that automatically checkpoints, migrates, and resumes live GPU jobs across computing instances to improve throughput, reliability, and performance.
1 investor
CedarDB builds high-performance database systems designed for modern hardware such as multicore processors, memory, and fast storage. Spun off from the Technical University of Munich's Umbra research project in 2024, the company develops database technology for demanding data workloads.
1 investor